SCIESCOPUSQ1
BIODRUGS
ADIS INT LTD
BIODRUGS is an academic journal published by ADIS INT LTD. Identifiers: ISSN 1173-8804, eISSN 1179-190X. Indexed in SCIE, SCOPUS. Metrics: JIF 6.9, CiteScore 10.6, SJR 2.290, SNIP 1.62. Subject areas: IMMUNOLOGY, ONCOLOGY, PHARMACOLOGY & PHARMACY. tlooto lists 1,782 papers from this journal.
CiteScore
10.60
Scopus citation metric
SJR
2.290
SCImago rank
SNIP
1.62
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 1173-8804
- eISSN
- 1179-190X
- Abbreviation
- BIODRUGS
- Publisher
- ADIS INT LTD
- Country
- -
Web of Science categories
SCIEIMMUNOLOGY, ONCOLOGY, PHARMACOLOGY & PHARMACY
Scopus ASJC categories
1305 Biotechnology2736 Pharmacology (medical)3004 Pharmacology
Keywords
Oncology | Immunology | Pharmacology & Pharmacy
Papers in this journal
Recent papers
- Interleukin-23 Inhibitors in Inflammatory Bowel Disease
2026
- Programmed Cell Death Protein 1-Interleukin-2 Bispecific Agents for Cancer Therapy
2026
- Impact of Repeated Antigen Exposure on Humoral Tolerance: Antidrug Antibodies After Single-Dose Versus Multi-dose Adalimumab.
2026
- Correction: Real-World Use of Dostarlimab Plus Chemotherapy in Advanced or Recurrent Endometrial Cancer: A Nationwide Cohort Study in France
2026
- Navigating the Transition: A Scoping Review of System-Level Factors in Biosimilar Integration for Immune-Mediated Inflammatory Diseases
2026
Most cited papers
- Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
2017 · 1,131 citations
- The Impact of PEGylation on Biological Therapies
2012 · 926 citations
- The Therapeutic Potential of Nanobodies
2019 · 629 citations
- Interleukin-10
2012 · 474 citations
- Glycosylation of Therapeutic Proteins: An Effective Strategy to Optimize Efficacy
2010 · 427 citations